Nuo Therapeutics, Inc.
AURX
$1.50
$0.1259.09%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -496.70K | -578.20K | -540.10K | -708.80K | -653.20K |
| Total Depreciation and Amortization | 28.40K | 20.50K | 19.90K | 27.50K | 27.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -42.10K | 50.90K | 3.10K | 20.60K | 63.10K |
| Change in Net Operating Assets | 19.90K | 19.30K | -174.10K | 98.20K | -108.30K |
| Cash from Operations | -490.50K | -487.50K | -691.20K | -562.40K | -671.40K |
| Capital Expenditure | 0.00 | -150.90K | -4.10K | -- | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 0.00 | -150.90K | -4.10K | -- | 0.00 |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 90.40K | 849.10K | 802.10K | -- | 962.50K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 90.40K | 849.10K | 802.10K | -- | 962.50K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | 0.00 |
| Net Change in Cash | -400.10K | 210.80K | 106.80K | -562.40K | 291.10K |